×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Introduction and Pre-Recorded Session 1: Drug Development: An Overview
Session Chair(s)
Elliott Berger, PhD, MS
President
ETB Regualtory Consulting, United States
- Introduction to Drug Development
- Regulation Highlights
- Key Definitions
- Drug Development Highlights
- Regulatory Strategy
Have an account?